Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort ... as the brand, namely maintenance ...
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a recently-launched authorised generic from AZ’s collaborator Prasco helping to ...
including inhalers Symbicort, Breztri Aerosphere and Airsupra. The cap will be applicable for patients who are uninsured or underinsured. The announcement follows a similar move by rival company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results